Price of new hepatitis C drug questioned by U.S. medical experts
Tuesday, March 11, 2014 - 14:00
in Mathematics & Economics
An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc.